{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-07",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0006-5083",
      "generic_name": "pembrolizumab and berahyaluronidase alfa-pmph",
      "labeler_name": "Merck Sharp & Dohme LLC",
      "brand_name": "KEYTRUDA QLEX",
      "active_ingredients": [
        {
          "name": "PEMBROLIZUMAB",
          "strength": "165 mg/mL"
        },
        {
          "name": "BERAHYALURONIDASE ALFA",
          "strength": "2000 U/mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0006-5083-01",
          "description": "1 VIAL in 1 CARTON (0006-5083-01)  / 4.8 mL in 1 VIAL (0006-5083-99)",
          "marketing_start_date": "20250919",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Merck Sharp & Dohme LLC"
        ],
        "rxcui": [
          "2723762",
          "2723769",
          "2723771",
          "2723772"
        ],
        "spl_set_id": [
          "097d166f-b73b-41d3-9b37-7653cd2a0c41"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000191260",
          "N0000191259",
          "N0000175531",
          "M0009499"
        ],
        "pharm_class_epc": [
          "Programmed Death Receptor-1 Blocking Antibody [EPC]",
          "Endoglycosidase [EPC]"
        ],
        "pharm_class_moa": [
          "Programmed Death Receptor-1-directed Antibody Interactions [MoA]"
        ],
        "pharm_class_cs": [
          "Glycoside Hydrolases [CS]"
        ],
        "unii": [
          "DPT0O3T46P",
          "9X4R4A4HQQ"
        ]
      },
      "marketing_category": "BLA",
      "dosage_form": "INJECTION, SOLUTION",
      "spl_id": "18b3adae-863b-413b-8e36-e3551115db37",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "SUBCUTANEOUS"
      ],
      "marketing_start_date": "20250919",
      "product_id": "0006-5083_18b3adae-863b-413b-8e36-e3551115db37",
      "application_number": "BLA761467",
      "brand_name_base": "KEYTRUDA QLEX",
      "pharm_class": [
        "Endoglycosidase [EPC]",
        "Glycoside Hydrolases [CS]",
        "Programmed Death Receptor-1 Blocking Antibody [EPC]",
        "Programmed Death Receptor-1-directed Antibody Interactions [MoA]"
      ]
    }
  ]
}